# Clinical observations of exenatide treatment.

> PubMed lists PMID 16873820 in Diabetes care as Letter, with publication-date metadata of 2006-08 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-16873820-exenatide:v1`
- Evidence domain: Literature metadata
- Date in source: 2018-12-01
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-16873820-exenatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-16873820-exenatide-v1.json
- Content SHA-256: `c1c74749661fbc2badbaf0a880455744824430fcb9641990be7fd9bde29e8780`

## Claims and source pins

### Headline

Clinical observations of exenatide treatment. ([`pubmed-observation-pmid-16873820-2018-12-01-dbd81a0f3835`](#source-pubmed-observation-pmid-16873820-2018-12-01-dbd81a0f3835))

### Summary

PubMed lists PMID 16873820 in Diabetes care as Letter, with publication-date metadata of 2006-08 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-16873820-2018-12-01-dbd81a0f3835`](#source-pubmed-observation-pmid-16873820-2018-12-01-dbd81a0f3835))

### Paragraph 1

PubMed lists PMID 16873820 in Diabetes care as Letter, with publication-date metadata of 2006-08 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-16873820-2018-12-01-dbd81a0f3835`](#source-pubmed-observation-pmid-16873820-2018-12-01-dbd81a0f3835))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-16873820-2018-12-01-dbd81a0f3835`](#source-pubmed-observation-pmid-16873820-2018-12-01-dbd81a0f3835))

## Sources

<a id="source-pubmed-observation-pmid-16873820-2018-12-01-dbd81a0f3835"></a>
- **Clinical observations of exenatide treatment. · retained source version 1:2018-12-01:current:dbd81a0f3835988a3e0ec34197012f3a9144a6c3b377e5ff9dc9793b4150e34b** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/16873820/) (`pubmed-observation-pmid-16873820-2018-12-01-dbd81a0f3835`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Clinical observations of exenatide treatment." Version 1, published 2026-08-16. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-16873820-exenatide-v1.json SHA-256: c1c74749661fbc2badbaf0a880455744824430fcb9641990be7fd9bde29e8780.